Abstract: The present invention relates to a Tabletting aid with a low water content and to a process for the preparation thereof. The Tabletting aid composition is a directly compressible composition, the use of which results in improved tablet properties.
Type:
Application
Filed:
March 22, 2017
Publication date:
July 6, 2017
Applicant:
Merck Patent GmbH
Inventors:
James EASSON, Walter HAMM, Guenter MODDELMOG
Abstract: The invention relates to mesogenic media comprising one or more bimesogenic compounds, one or more nematogenic compound, one or more chiral compound and a compound of formula I, R11-A11-(Z12-A12)m-AG??I in which, the parameter A11, A12, Z12 and R11 have one of the meanings as given in claim 1, and to the use of these mesogenic media in liquid crystal devices and in particular in flexoelectric liquid crystal devices, as well as to liquid crystal devices comprising a liquid crystal medium according to the present invention.
Type:
Application
Filed:
June 15, 2015
Publication date:
July 6, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Owain Ilyr PARRI, Graziano ARCHETTI, Simon SIEMIANOWSKI, Izumi SAITO, Rachel TUFFIN
Abstract: The present invention relates to polymers containing 2,7-pyrene structural units, to a process for the preparation thereof, and to blends and formulations comprising these polymers. The present invention furthermore relates to the use of the polymers or blends according to the invention in electronic devices and to electronic devices, in particular OLEDs, comprising the polymers or blends according to the invention.
Abstract: The present invention relates to a formulation with which electronic devices can be produced with improved performance with respect to operating voltage, efficiency and service life. The present invention likewise relates to a method for producing a formulation according to the invention and to a method for producing electronic devices using the formulation according to the invention. Furthermore, the present invention also relates to an electronic device that has been produced using the method according to the invention.
Type:
Grant
Filed:
October 30, 2013
Date of Patent:
July 4, 2017
Assignee:
Merck Patent GmbH
Inventors:
Herwig Buchholz, Thomas Eberle, Junyou Pan
Abstract: A biocidal fluid purification cap (2) for a fluid container (1), preferably one storing purified water for use in laboratory environments and especially purified water for cell culture and water for molecular biology. The purification cap (2) includes a cap body (3) including an engagement feature (20) for removably attaching the cap body (3) to a mating engagement feature on a spout of the fluid container (1) to hermetically close a spout opening, at least one LED (7a) adapted to emit light in the UV-C range, electronic circuitry (15) for driving the LED(s) (7a), and a power supply for the electronic circuitry (15). The LED(s) (7a) is/are arranged in said cap body (3) so as to be separated from the environment by an UV-transparent window (6) provided in the cap body (3) such that light emitted from said LED(s) (7a) enters the opening of the spout when the cap (2) is attached to the spout of the container (1).
Abstract: The invention relates to novel conjugated polymers containing one or more thieno[3,2-b]thiophene based polycyclic repeating units, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.
Type:
Grant
Filed:
June 4, 2013
Date of Patent:
July 4, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
William Mitchell, Mansoor D'Lavari, Changsheng Wang, Steven Tierney, David Sparrowe
Abstract: The present invention relates to tetrahydro-tetrazolo[1,5-a]pyrazine compounds of formula (I), wherein R1 denotes —R3, —CH2—R3 or —CO—R3; R2 denotes Ar2, Hetar2 or C3-7-cycloalkyl; and R3 denotes Ar3, Hetar3 or C3-7-cycloalkyl. These compounds are useful for inhibiting the retinoid-related orphan receptor ? (ROR ?, ROR-gamma) and for the prevention and/or treatment of medical conditions affected by ROR ? activity such as rheumatoid arthritis, multiple sclerosis, psoriasis, ulcerative colitis, asthma, autoimmune hepatitis or type 1 and type 2 diabetes.
Abstract: The invention generally relates to passivation layers for use in organic electronic devices, and more specifically in organic field effect transistors, to processes for preparing such passivation layers, and to organic electronic devices and organic field effect transistors encompassing such passivation layers.
Type:
Grant
Filed:
August 22, 2013
Date of Patent:
June 27, 2017
Assignee:
Merck Patent GmbH
Inventors:
Stephen Bain, Irina Afonina, Tomas Backlund, Paul Craig Brookes
Abstract: The present invention relates inter alia to an array comprising i times j array elements, wherein the array elements may comprise at least one quantum dot and/or at least one photoluminescent compound. Further the present invention relates to devices comprising these arrays. The arrays and devices can be used to generate white light with high color purity.
Type:
Grant
Filed:
April 28, 2011
Date of Patent:
June 27, 2017
Assignee:
Merck Patent GmbH
Inventors:
Junyou Pan, Niels Schulte, Thomas Eberle
Abstract: The present invention relates to secondary amines suitable for the preparation of ligands for organometallic complexes, their preparation and their use.
Abstract: The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
Abstract: The invention is directed to cancer immunotherapy. The invention is specifically directed to the induction of innate or adaptive antitumor immunity initiated by the administration of targeted IL-12 molecules preferably in conjunction with IL-2 and/or IL-7 to a cancer patient, who suffers from cancer of the muscle, bone, nerves, cartilage, tendons, blood vessels, etc., preferably from sarcoma. The invention is specifically related to the use of IL-12 in form of the specific immunoglobulin cytokine fusion protein called NHS-IL12, preferably in combination with a form of IL-2 and/or IL-7 exhibiting prolonged pharmacokinetics for the treatment of said cancer diseases.
Type:
Application
Filed:
February 18, 2015
Publication date:
June 15, 2017
Applicant:
Merck Patent GmbH
Inventors:
Wolfgang Strittmatter, Rupert Handgretinger, Karin Schilbach-Stueckle
Abstract: This invention relates to a method for producing a photodetector based on the deposition of precursor system having a liquid phase. The photodetectors are characterized by a certain group of semiconductor materials which can be used as the absorber in solar-blind UV detectors. A facile route for the formation of thin layers of such absorber materials is disclosed.
Type:
Application
Filed:
January 16, 2015
Publication date:
June 15, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Rebekah HOOKER, Deepak Ranjan DESHMUKH, Pawel MISKIEWICZ, Andreas KLYSZCZ, Klaus BONRAD, Thomas ALBRECHT
Abstract: This invention relates generally to bifunctional molecules including (a) a TGF?RII or fragment thereof capable of binding TGF? and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g., for treating cancer), and methods of making such molecules.
Abstract: The present invention provides a liquid-crystal display device capable of maintaining a high voltage holding ratio even without an alignment film. The liquid-crystal display device of the present invention includes a pair of substrates, a liquid crystal layer which is sandwiched between the substrates and which contains a liquid crystal material, and a polymer layer which is disposed on a surface of each of the substrates and which controls the alignment of liquid crystal molecules. The outermost surfaces of both the substrates comprise substantially no alignment film. The polymer layer is formed by polymerizing one or more radical polymerizable monomer species added to the liquid crystal layer. At least one species of the one or more radical polymerizable monomer species is a biphenyl compound having a specific structure.
Abstract: The invention relates to novel conjugated polymers containing one or more repeating units derived from indacenodibenzothiophene or dithia-dicyclopenta-dibenzothiophene, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.
Type:
Grant
Filed:
April 2, 2013
Date of Patent:
June 13, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Mansoor D'Lavari, William Mitchell, Changsheng Wang, Steven Tierney, David Sparrowe
Abstract: The invention relates to extended non-linear acene derivatives, methods of their preparation, their use as semiconductors in organic electronic (OE) devices, and OE devices comprising them.
Type:
Application
Filed:
June 3, 2015
Publication date:
June 8, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
William MITCHELL, Mansoor D'LAVARI, Changsheng WANG, David SPARROWE
Abstract: The present invention relates to a rotary printing process for the application of functional coatings to a print substrate, to a coated print substrate produced by the said process, and to the use thereof, in particular in the packaging sector.
Type:
Application
Filed:
October 28, 2014
Publication date:
June 8, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Andreas BECKER, Thomas RATHSCHLAG, Johannes TASCH